Extended Data Fig. 1: Cummulative Incidence of Intracranial Progression-Free Survival, with Extracranial Progression as a Competing Risk.
Competing risk analysis was performed for all 15 patients enrolled on trial. At 6 months, the proportion of patients who were intracranial progression free was 0.60 (90% CI: 0.34-0.79).
